美国的Salix医药公司称,发表在第8期《当代药物研究与观点》的一篇新近研究结果显示,200mg Xifaxan(rifaximin,利福昔明)片剂(Ⅰ)有可能成为活动性局限性肠炎(CD)的有效治疗药.该药是一种肠选择性,非全身吸收(低于0.4%)的口服抗生素,去年在美国被批准用于治疗由非侵犯性大肠杆菌菌株引起的12岁以上患者的旅行者腹泻....
通用名: 利福昔明片 买参比 找麦冬生物 QQ2645497356 商品名: Xifaxan 购买咨询 QQ2645497356 英文名: Rifaximin Tabiels 规格: 200mg 剂型: 0 持证商: Alfasigma S.p.A 参比制剂目录: 43-2 征求意见稿 买参比制剂 找麦冬生物QQ2645497356 上市国家: 原研进口 备注1: 国内上市的原研药品 买参比...
(Doxycycline 100mg100mg) $ 0.76 Furadantin (Nitrofurantoin 50/100mg50/100mg) $ 0.61 Ilosone (Erythromycin 250/500mg250/500mg) Product Information Rifaximin tablet What is this medicine? RIFAXIMIN is an antibiotic that fights bacterial infection only in the intestines. ...
Travelers’ Diarrhea Systemic absorption of XIFAXAN (200 mg three times daily) was evaluated in 13 subjects challenged with shigellosis on Days 1 and 3 of a three-day course of treatment. Rifaximin plasma concentrations and exposures were low and variable. There was no evidence of accumulation of...
Rifaximin works differently from other antibiotics because it passes through your stomach and into your intestines without being absorbed into your blood stream. Because rifaximin treats only the intestinal tract, it will not treat infections of other parts of the body. ...
Xifaxan (rifaximin) is commonly used for the following conditions. Treatment of travelers’ diarrhea (TD), an intestinal infection caused by eating or drinking contaminated food or water. Xifaxan may not be appropriate for some travelers’ diarrhea infections, depending on which germs are causing the...
产品货号 16131-100 产品报价 ￥询价/100mg 产品说明书 点击查看 购买方式 银行转账、电汇、支票、现金,在线支付宝及网银支付,或直接与我们电话联系400-6800-868 产品新闻 背景资料 Rifaximin is an antibiotic derived from rifamycin that targets most Gram-positive and Gram-negative bacteria.{26321} As it is...
Rifaximin Brand Name : Dosage Form :Film Coated Tablet Dosage Strength :200MG Packaging : Approval Date : Application Number : Portfolio PDF Product Web Link Virtual Booth Digital Content Website Corporate PDF ALFRED E TIEFENBACHER GmbH & Co KG ...
2010年3月,美国FDAj比准了Salix制药有限公司的利福昔明(rifaximin)55()nag 片剂Xifixan的新药申请,用 于减少≥18岁终末期肝病患者的显性肝性脑病复发风险利福昔明是近3f)年来在 美获准用于治疗此类患者的第一种 药物,其200mg片剂先前已在美国获准治疗由大肠杆菌引起的≥12岁旅行者腹 ...
Rifaximin [Xifaxan; Salix Pharmaceuticals] 200mg tablets were recently shipped throughout the US,NA;Inpharma weekly